Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Abstract CT035: TP53 abnormalities correlate with immune infiltration and are associated with response to flotetuzumab, an investigational immunotherapy, in acute myeloid leukemia

Jayakumar Vadakekolathu, Catherine Lai, Stephen Reeder, Sarah E. Church, Tressa Hood, John Muth, Heidi Altmann, Marilena Ciciarello, Antonio Curti, Peter J. Valk, Bob Löwenberg, Martin Bornhäuser, John F. DiPersio, Jan K. Davidson-Moncada, Sergio Rutella

Cancer Res (2020) 80 (16_Supplement): CT035.

https://doi.org/10.1158/1538-7445.AM2020-CT035

Published: 15 August 2020

View articletitled, Abstract CT035: TP53 abnormalities correlate with immune infiltration and are associated with response to flotetuzumab, an investigational immunotherapy, in acute myeloid leukemia

Journal Articles

JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia—Letter

Malte von Bonin, Katharina Moll, Michael Kramer, Uta Oelschlägel, Martin Wermke, Christoph Röllig, Christian Thiede, Gerhard Ehninger, Alwin Krämer, Carsten Müller-Tidow, Ioannis Mitroulis, Martin Bornhäuser

Cancer Res (2018) 78 (21): 6339–6341.

https://doi.org/10.1158/0008-5472.CAN-18-0642

Published: 01 November 2018

View articletitled, JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia—Letter

Journal Articles

Abstract #4184: Reciprocal activating interaction between 6-sulfo LacNAc⁺ dendritic cells and NK cells in antitumor immunity

Marc Schmitz, Rebekka Wehner, Bärbel Löbel, Martin Bornhäuser, Michael Bachmann, Ernst Peter Rieber

Cancer Res (2009) 69 (9_Supplement): 4184.

Published: 01 May 2009

View articletitled, Abstract #4184: Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells in antitumor immunity

Journal Articles

Reciprocal activating interaction between native human blood dendritic cells and innate effector cells in antitumor immunity

Marc Schmitz, Rebekka Wehner, Barbel Lobel, Martin Bornhauser, Ernst Peter Rieber

Cancer Res (2008) 68 (9_Supplement): 257.

Published: 01 May 2008

View articletitled, Reciprocal activating interaction between native human blood dendritic cells and innate effector cells in antitumor immunity

Journal Articles

Adoptive transfer of peptide-reactive donor T cells to prevent relapse of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation

Martin Bornhauser, Jana Babatz, Johannes Schetelig, Thomas Illmer, Alexander Kiani, Uwe Platzbecker, Christian Thiede, Ernst Rieber, Gerhard Ehninger, Marc Schmitz

Cancer Res (2007) 67 (9_Supplement): LB-176.

Published: 01 May 2007

View articletitled, Adoptive transfer of peptide-reactive donor T cells to prevent relapse of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation

Journal Articles

Native blood dendritic cells exhibit direct tumor cell killing and improve the tumoricidal activaty of NK cells

Marc Schmitz, Senming Zhao, Yvonne Deuse, Rebekka Wehner, Knut Schäkel, Martin Bornhauser, Ernst Peter Rieber

Cancer Res (2005) 65 (9_Supplement): 1000–1001.

Published: 01 May 2005

View articletitled, Native blood dendritic cells exhibit direct tumor cell killing and improve the tumoricidal activaty of NK cells

Journal Articles

Third International Dresden Symposium on Immunotherapy of Cancer

Marc Schmitz, Martin Bornhauser, Detlef Ockert, Ernst Peter Rieber

Cancer Res (2001) 61 (8): 3524–3528.

Published: 15 April 2001

View articletitled, Third International Dresden Symposium on Immunotherapy of Cancer

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract CT035: TP53 abnormalities correlate with immune infiltration and are associated with response to flotetuzumab, an investigational immunotherapy, in acute myeloid leukemia

JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia—Letter

Abstract #4184: Reciprocal activating interaction between 6-sulfo LacNAc⁺ dendritic cells and NK cells in antitumor immunity

Reciprocal activating interaction between native human blood dendritic cells and innate effector cells in antitumor immunity

Adoptive transfer of peptide-reactive donor T cells to prevent relapse of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation

Native blood dendritic cells exhibit direct tumor cell killing and improve the tumoricidal activaty of NK cells

Third International Dresden Symposium on Immunotherapy of Cancer

Email alerts

AACR Journals

Update search

Abstract CT035: TP53 abnormalities correlate with immune infiltration and are associated with response to flotetuzumab, an investigational immunotherapy, in acute myeloid leukemia

JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia—Letter

Abstract #4184: Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells in antitumor immunity

Reciprocal activating interaction between native human blood dendritic cells and innate effector cells in antitumor immunity

Adoptive transfer of peptide-reactive donor T cells to prevent relapse of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation

Native blood dendritic cells exhibit direct tumor cell killing and improve the tumoricidal activaty of NK cells

Third International Dresden Symposium on Immunotherapy of Cancer

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Abstract #4184: Reciprocal activating interaction between 6-sulfo LacNAc⁺ dendritic cells and NK cells in antitumor immunity